• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人副流感病毒3型的血凝素神经氨酸酶:神经氨酸酶在病毒生命周期中的作用

Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.

作者信息

Huberman K, Peluso R W, Moscona A

机构信息

Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

出版信息

Virology. 1995 Dec 1;214(1):294-300. doi: 10.1006/viro.1995.9925.

DOI:10.1006/viro.1995.9925
PMID:8525632
Abstract

The function of neuraminidase in the life cycle and pathogenesis of human parainfluenza virus type 3 (HPF3) was studied by analyzing a variant of HPF3 that has decreased neuraminidase enzymatic activity. The variant virus is more fusogenic than the wild-type virus during an acute infection. Cloning and sequencing of the fusion (F) and hemagglutinin-neuraminidase (HN) genes from this variant revealed a single amino acid change in the HN protein and no alterations in the F protein sequence. Analysis of the growth properties of this variant revealed a delay in release of virus particles into the supernatant. Addition of exogenous neuraminidase to the culture resulted in increased release of infections viral particles, suggesting that the viral neuraminidase is important for release of HPF3 from the infected cell surface. In addition, the behavior of the variant virus during high-multiplicity infection and in the presence of exogenous neuraminidase provided evidence that the neuraminidase of HPF3 determines the outcome of viral infection (cytopathic versus persistent) in cell culture.

摘要

通过分析一种神经氨酸酶酶活性降低的3型人副流感病毒(HPF3)变体,研究了神经氨酸酶在HPF3生命周期和发病机制中的作用。在急性感染期间,该变体病毒比野生型病毒更具融合性。对该变体的融合(F)基因和血凝素神经氨酸酶(HN)基因进行克隆和测序,结果显示HN蛋白中有一个氨基酸发生了变化,而F蛋白序列没有改变。对该变体生长特性的分析表明,病毒颗粒释放到上清液中的过程有所延迟。向培养物中添加外源性神经氨酸酶会导致感染性病毒颗粒的释放增加,这表明病毒神经氨酸酶对于HPF3从受感染细胞表面释放至关重要。此外,该变体病毒在高倍感染期间以及在外源性神经氨酸酶存在的情况下的行为提供了证据,表明HPF3的神经氨酸酶决定了细胞培养中病毒感染的结果(细胞病变与持续性)。

相似文献

1
Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.人副流感病毒3型的血凝素神经氨酸酶:神经氨酸酶在病毒生命周期中的作用
Virology. 1995 Dec 1;214(1):294-300. doi: 10.1006/viro.1995.9925.
2
Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.1、2和3型人副流感病毒的病毒-受体相互作用
Microb Pathog. 1999 Nov;27(5):329-36. doi: 10.1006/mpat.1999.0313.
3
The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.使用定量融合测定法评估人副流感病毒3型的HN受体相互作用。
Virology. 1999 Dec 5;265(1):57-65. doi: 10.1006/viro.1999.0024.
4
A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.人副流感病毒3型血凝素-神经氨酸酶糖蛋白中的单个氨基酸改变赋予了对扎那米韦受体结合抑制作用和神经氨酸酶活性的抗性。
J Virol. 2001 Jul;75(14):6310-20. doi: 10.1128/JVI.75.14.6310-6320.2001.
5
Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.人副流感病毒3型HN受体相互作用:4-胍基-Neu5Ac2en对神经氨酸酶缺陷变体的影响
J Virol. 2001 Aug;75(16):7481-8. doi: 10.1128/JVI.75.16.7481-7488.2001.
6
Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.人副流感病毒3型受体结合变体分析:使用特定含唾液酸受体的证据
Microb Pathog. 1996 Mar;20(3):179-84. doi: 10.1006/mpat.1996.0016.
7
Persistent infection with human parainfluenza virus 3 in CV-1 cells: analysis of the role of defective interfering particles.CV-1细胞中人类副流感病毒3型的持续感染:缺陷干扰颗粒作用的分析
Virology. 1993 May;194(1):399-402. doi: 10.1006/viro.1993.1275.
8
Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.人副流感病毒3型HN受体相互作用对体内发病机制的作用。
J Virol. 2001 Dec;75(24):12446-51. doi: 10.1128/JVI.75.24.12446-12451.2001.
9
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein.融合蛋白对仙台病毒血凝素神经氨酸酶的抑制作用。
Biochem Biophys Res Commun. 1994 Jun 15;201(2):988-93. doi: 10.1006/bbrc.1994.1799.
10
Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.人副流感病毒3型附着蛋白的神经氨酸酶活性对其激活融合蛋白能力的影响。
J Virol. 2005 Feb;79(4):2383-92. doi: 10.1128/JVI.79.4.2383-2392.2005.

引用本文的文献

1
Identification of β4GALNT2 as an anti-hPIV3 factor through genome-wide CRISPR/Cas9 library screening.通过全基因组CRISPR/Cas9文库筛选鉴定β4GALNT2作为抗人副流感病毒3型因子
Emerg Microbes Infect. 2025 Dec;14(1):2529895. doi: 10.1080/22221751.2025.2529895. Epub 2025 Jul 16.
2
Unraveling dynamics of paramyxovirus-receptor interactions using nanoparticles displaying hemagglutinin-neuraminidase.利用展示血凝素-神经氨酸酶的纳米颗粒揭示副粘病毒-受体相互作用的动力学。
PLoS Pathog. 2024 Jul 25;20(7):e1012371. doi: 10.1371/journal.ppat.1012371. eCollection 2024 Jul.
3
Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies.
人源单克隆抗体对3型人副流感病毒中和作用的功能和结构基础
Nat Microbiol. 2024 Aug;9(8):2128-2143. doi: 10.1038/s41564-024-01722-w. Epub 2024 Jun 10.
4
Parainfluenza virus entry at the onset of infection.副流感病毒在感染初期的进入。
Adv Virus Res. 2021;111:1-29. doi: 10.1016/bs.aivir.2021.07.001. Epub 2021 Aug 23.
5
Human parainfluenza virus evolution during lung infection of immunocompromised individuals promotes viral persistence.免疫功能低下个体肺部人副流感病毒感染期间的进化促进了病毒的持续存在。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI150506.
6
Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase.探索与人类3型副流感病毒血凝素神经氨酸酶216环结合所需的抑制剂结构特征。
Medchemcomm. 2016 Oct 5;8(1):130-134. doi: 10.1039/c6md00519e. eCollection 2017 Jan 1.
7
Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.在病毒分离过程中,快速的基因组变化导致病毒适应人体所需的进入特性丧失。
mBio. 2018 Jul 3;9(4):e00898-18. doi: 10.1128/mBio.00898-18.
8
Parainfluenza Virus Infection.副流感病毒感染
Semin Respir Crit Care Med. 2016 Aug;37(4):538-54. doi: 10.1055/s-0036-1584798. Epub 2016 Aug 3.
9
A dual drug regimen synergistically blocks human parainfluenza virus infection.双药疗法可协同阻断人副流感病毒感染。
Sci Rep. 2016 Apr 7;6:24138. doi: 10.1038/srep24138.
10
Features of Circulating Parainfluenza Virus Required for Growth in Human Airway.人呼吸道生长所需的循环副流感病毒的特征
mBio. 2016 Mar 15;7(2):e00235. doi: 10.1128/mBio.00235-16.